Ausgabe 1/2003
Inhalt (28 Artikel)
A proposed architecture and method of operation for improving the protection of privacy and confidentiality in disease registers
Tim Churches
Development and evaluation of a quality score for abstracts
Antje Timmer, Lloyd R Sutherland, Robert J Hilsden
Performance of health-status scales when used selectively or within multi-scale questionnaire
Christina Gummesson, Isam Atroshi, Charlotte Ekdahl
Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening
Stuart G Baker, Diane Erwin, Barnett S Kramer, Philip C Prorok
Estimation of the correlation coefficient using the Bayesian Approach and its applications for epidemiologic research
Enrique F Schisterman, Kirsten B Moysich, Lucinda J England, Malla Rao
Design of Phase II cancer trials evaluating survival probabilities
L Douglas Case, Timothy M Morgan
Choosing a control intervention for a randomised clinical trial
Howard Mann, Benjamin Djulbegovic
A simple method for analyzing data from a randomized trial with a missing binary outcome
Stuart G Baker, Laurence S Freedman
Randomized trials, generalizability, and meta-analysis: Graphical insights for binary outcomes
Stuart G Baker, Barnett S Kramer
Estimating the cumulative risk of false positive cancer screenings
Stuart G Baker, Diane Erwin, Barnett S Kramer
More insight into the fate of biomedical meeting abstracts: a systematic review
Erik von Elm, Michael C Costanza, Bernhard Walder, Martin R Tramèr
Identifying null meta-analyses that are ripe for updating
Nicholas J Barrowman, Manchun Fang, Margaret Sampson, David Moher
Interim analyses of data as they accumulate in laboratory experimentation
John Ludbrook
A perfect correlate does not a surrogate make
Stuart G Baker, Barnett S Kramer
Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint
Richard M Nixon, Stephen W Duffy, Guy RK Fender
How does correlation structure differ between real and fabricated data-sets?
Noori Akhtar-Danesh, Mahshid Dehghan-Kooshkghazi
The reporting of methods for reducing and detecting bias: an example from the WHO Misoprostol Third Stage of Labour equivalence randomised controlled trial
Gilda Piaggio, Diana Elbourne, Kenneth F Schulz, José Villar, Alain PY Pinol, A Metin Gülmezoglu
Interdisciplinary research: putting the methods under the microscope
David W Robertson, Douglas K Martin, Peter A Singer
Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio
Aluísio JD Barros, Vânia N Hirakata
How many repeated measures in repeated measures designs? Statistical issues for comparative trials
Andrew J Vickers
Erratum to: The transitive fallacy for randomized trials: If A bests B and B bests C in separate trials, is A better than C?
Stuart G Baker, Barnett S Kramer
Recruitment of heterosexual couples in public health research: a study protocol
James M McMahon, Stephanie Tortu, Leilani Torres, Enrique R Pouget, Rahul Hamid
The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews
Penny Whiting, Anne WS Rutjes, Johannes B Reitsma, Patrick MM Bossuyt, Jos Kleijnen
Design, analysis and presentation of factorial randomised controlled trials
Alan A Montgomery, Tim J Peters, Paul Little
A framework for power analysis using a structural equation modelling procedure
Jeremy Miles
Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity
Marshall Godwin, Lucia Ruhland, Ian Casson, Susan MacDonald, Dianne Delva, Richard Birtwhistle, Miu Lam, Rachelle Seguin